A phase II trial of bevacizumab with dacarbazine and daily low-dose interferon-alpha2a as first line treatment in metastatic melanoma
| Image |  |
|---|---|
| Description | scientific article published in August 2010 |
| Author/s |
author: Johan Lundin Pia Vihinen Johanna Ivaska |
| Publication date | August 1, 2010 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |